Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition, the company sells dietary supplements, cosmetics, and dermo cosmetics. The company was founded in 2010 and is based in Nakhon Pathom, Thailand.
Metrics to compare | MEDEZE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDEZEPeersSector | |
---|---|---|---|---|
P/E Ratio | 22.1x | 17.2x | −0.5x | |
PEG Ratio | 6.09 | −0.82 | 0.00 | |
Price/Book | 2.6x | 1.8x | 2.6x | |
Price / LTM Sales | 8.7x | 1.5x | 3.2x | |
Upside (Analyst Target) | 52.4% | 32.4% | 41.7% | |
Fair Value Upside | Unlock | 27.6% | 6.1% | Unlock |